{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Tactile Systems Technology, Inc.
Is Tactile Systems Technology, Inc. overvalued or undervalued?
As of October 17, 2025, Tactile Systems Technology, Inc. is considered overvalued with a fair valuation grade, reflected by its P/E ratio of 14 and poor year-to-date performance of -15.18% compared to the S&P 500's 13.30%.
Tactile Systems Technology, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
Tactile Systems Technology, Inc. has recently adjusted its valuation, with its stock price at $14.53. Over the past year, it has returned 1.96%, underperforming the S&P 500. Key metrics include a P/E ratio of 14 and a ROCE of 13.69%, reflecting its operational efficiency amid a competitive industry landscape.
Is Tactile Systems Technology, Inc. overvalued or undervalued?
As of October 17, 2025, Tactile Systems Technology, Inc. is fairly valued with a P/E ratio of 14, a Price to Book Value of 1.14, and an EV to EBITDA ratio of 6.49, indicating a stable valuation compared to its peers.
Is Tactile Systems Technology, Inc. overvalued or undervalued?
As of October 17, 2025, Tactile Systems Technology, Inc. is fairly valued with a P/E ratio of 14, having recently outperformed the S&P 500 over the past week and month, but lagging year-to-date and over the past year, making it less attractive compared to peers like CareDx, Inc. and Organogenesis Holdings, Inc.
Tactile Systems Technology Forms Golden Cross, Signals Bullish Breakout Ahead
Tactile Systems Technology, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Technical indicators suggest a bullish trend, despite a year-to-date decline. Over the past three years, the stock has significantly outperformed the S&P 500, highlighting its resilience in the pharmaceuticals and biotechnology sector.
Is Tactile Systems Technology, Inc. technically bullish or bearish?
As of July 24, 2025, Tactile Systems Technology, Inc. shows a mildly bearish trend with mixed technical signals, including a bullish weekly MACD and bearish monthly MACD, while outperforming the S&P 500 recently but down 17.75% year-to-date.
Is Tactile Systems Technology, Inc. overvalued or undervalued?
As of August 15, 2025, Tactile Systems Technology, Inc. is fairly valued with a P/E ratio of 14 and has underperformed the market with a year-to-date return of -17.75%, compared to the S&P 500's 12.22% return.
Is Tactile Systems Technology, Inc. technically bullish or bearish?
As of June 18, 2025, Tactile Systems Technology, Inc. shows a mildly bearish trend with mixed signals, including bearish MACD and moving averages, but some bullish momentum in the RSI and KST, indicating potential for short-term gains.
Who are in the management team of Tactile Systems Technology, Inc.?
As of March 2022, Tactile Systems Technology, Inc.'s management team includes Peter Soderberg (Independent Chairman), Daniel Reuvers (CEO), Sheri Dodd, Deepti Jain, William Burke, Raymond Huggenberger, and Richard Nigon (all Independent Directors). They oversee the company's operations and strategic direction.
What does Tactile Systems Technology, Inc. do?
Tactile Systems Technology, Inc. is a medical technology company that develops home treatment devices for chronic diseases, classified as a micro-cap with a market cap of $228.07 million. As of March 2025, it reported net sales of $61 million and a net profit of -$3 million.
How big is Tactile Systems Technology, Inc.?
As of Jun 18, Tactile Systems Technology, Inc. has a market capitalization of 228.07 million and reported net sales of 293.16 million and a net profit of 16.21 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
